These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14983098)

  • 1. Evaluation of different linker regions for multimerization and coupling chemistry for immobilization of a proteinaceous affinity ligand.
    Linhult M; Gülich S; Gräslund T; Nygren PA; Hober S
    Protein Eng; 2003 Dec; 16(12):1147-52. PubMed ID: 14983098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and use of the serum albumin binding domains of streptococcal protein G.
    Nygren PA; Eliasson M; Abrahmsén L; Uhlén M; Palmcrantz E
    J Mol Recognit; 1988 Apr; 1(2):69-74. PubMed ID: 3273653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
    Simard JR; Zunszain PA; Hamilton JA; Curry S
    J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and characterization of Affibody ligands to the transcription factor c-Jun.
    Lundberg E; Brismar H; Gräslund T
    Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):17-27. PubMed ID: 18260830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of a femtomolar affinity binding protein to human serum albumin.
    Jonsson A; Dogan J; Herne N; Abrahmsén L; Nygren PA
    Protein Eng Des Sel; 2008 Aug; 21(8):515-27. PubMed ID: 18499681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions.
    Kawakami A; Kubota K; Yamada N; Tagami U; Takehana K; Sonaka I; Suzuki E; Hirayama K
    FEBS J; 2006 Jul; 273(14):3346-57. PubMed ID: 16857017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small bispecific protein selected for orthogonal affinity purification.
    Alm T; Yderland L; Nilvebrant J; Halldin A; Hober S
    Biotechnol J; 2010 Jun; 5(6):605-17. PubMed ID: 20518064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the tolerance of a protein a analogue to repeated alkaline exposures using a bypass mutagenesis approach.
    Linhult M; Gülich S; Gräslund T; Simon A; Karlsson M; Sjöberg A; Nord K; Hober S
    Proteins; 2004 May; 55(2):407-16. PubMed ID: 15048831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-linked dimerization in the iron-dependent regulator from Mycobacterium tuberculosis.
    Semavina M; Beckett D; Logan TM
    Biochemistry; 2006 Oct; 45(41):12480-90. PubMed ID: 17029403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of competitive binding of ligands to human serum albumin using NMR relaxation measurements.
    Cui YF; Bai GY; Li CG; Ye CH; Liu ML
    J Pharm Biomed Anal; 2004 Feb; 34(2):247-54. PubMed ID: 15013138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based mechanism of ligand binding for periplasmic solute-binding protein of the Bug family.
    Herrou J; Bompard C; Antoine R; Leroy A; Rucktooa P; Hot D; Huvent I; Locht C; Villeret V; Jacob-Dubuisson F
    J Mol Biol; 2007 Nov; 373(4):954-64. PubMed ID: 17870093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand binding to a human serum albumin stationary phase: use of same-drug competition to discriminate pharmacologically relevant interactions.
    Ascoli GA; Bertucci C; Salvadori P
    Biomed Chromatogr; 1998; 12(5):248-54. PubMed ID: 9787894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature-dependent simultaneous ligand binding in human serum albumin.
    Sinha SS; Mitra RK; Pal SK
    J Phys Chem B; 2008 Apr; 112(16):4884-91. PubMed ID: 18386863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extraordinary ligand binding properties of human serum albumin.
    Fasano M; Curry S; Terreno E; Galliano M; Fanali G; Narciso P; Notari S; Ascenzi P
    IUBMB Life; 2005 Dec; 57(12):787-96. PubMed ID: 16393781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements.
    Lucas LH; Price KE; Larive CK
    J Am Chem Soc; 2004 Nov; 126(43):14258-66. PubMed ID: 15506793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
    Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of stability at extreme alkaline pH in streptococcal protein G.
    Palmer B; Angus K; Taylor L; Warwicker J; Derrick JP
    J Biotechnol; 2008 Apr; 134(3-4):222-30. PubMed ID: 18304667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of the drug-binding specificity of human serum albumin.
    Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
    J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of daunomycin antibiotic with human serum albumin: investigation by resonant mirror biosensor technique, fluorescence spectroscopy and molecular modeling methods.
    Tang K; Qin YM; Lin AH; Hu X; Zou GL
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):404-10. PubMed ID: 15964731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.